Cargando…
1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss
Background: Selective proteinuria is frequently observed in glomerular diseases characterized by podocyte injury. Although, 1,25-dihydroxyvitamin D3 [1,25(OH)(2)D(3)] has potential therapeutic effects on chronic kidney diseases through decreasing podocyte loss, the mechanism underlying the beneficia...
Autores principales: | Zou, Min-shu, Yu, Jian, Nie, Guo-ming, He, Wei-sun, Luo, Li-man, Xu, Hong-tao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934728/ https://www.ncbi.nlm.nih.gov/pubmed/20827429 |
Ejemplares similares
-
1,25-Dihydroxyvitamin D(3) enhances the susceptibility of anaplastic thyroid cancer cells to adriamycin-induced apoptosis by increasing the generation of reactive oxygen species
por: Zhang, Ting, et al.
Publicado: (2019) -
1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria
por: Ma, Jianchao, et al.
Publicado: (2013) -
Adriamycin does not damage podocytes of zebrafish larvae
por: Schindler, Maximilian, et al.
Publicado: (2020) -
Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis
por: Li, Chih-Huang, et al.
Publicado: (2019) -
Role of C/EBP-α in Adriamycin-induced podocyte injury
por: Zhong, Fang, et al.
Publicado: (2016)